Table 1 Comparison of clinical characteristics between T2D and control groups without diabetes stratified by age
From: HDL levels modulate the impact of type 2 diabetes susceptibility alleles in older adults
T2D | noT2D ≥ 60 years | noT2D ≥ 65 years | noT2D ≥ 70 years | P1 | P2 | P3 | |
|---|---|---|---|---|---|---|---|
N | 2769 | 3167 | 2323 | 1545 | |||
Age | 62.61 (10.25) | 70.02 (6.97) | 72.96 (5.76) | 75.98 (4.65) | < 0.01 | < 0.01 | < 0.01 |
BMI (Kg/m2) | 29.92 (5.37) | 29.68 (56.75) | 29.95 (66.40) | 30.43 (81.54) | 0.82 | 0.98 | 0.75 |
Weight (Kg) | 80.62 (15.43) | 76.01 (14.61) | 75.03 (14.33) | 73.66 (13.43) | < 0.01 | < 0.01 | < 0.01 |
Total Cholesterol (mg/dL) | 181.16 (46.78) | 185.98 (46.18) | 183.46 (45.07) | 181.94 (45.35) | < 0.01 | 0.11 | 0.63 |
LDL Cholesterol (mg/dL) | 106.23 (40.69) | 111.98 (38.77) | 109.86 (38.01) | 108.81 (38.26) | < 0.01 | < 0.01 | 0.07 |
HDL Cholesterol (mg/dL) | 39.50 (11.94) | 44.15 (13.90) | 44.52 (14.08) | 44.69 (14.45) | < 0.01 | < 0.01 | < 0.01 |
Triglyceride (mg/dL) | 197.92 (131.79) | 155.15 (80.71) | 150.88 (75.89) | 146.91 (72.39) | < 0.01 | < 0.01 | < 0.01 |
Glucose (mg/dL) | 159.36 (66.96) | 106.43 (33.83) | 106.19 (27.74) | 105.60 (24.42) | < 0.01 | < 0.01 | < 0.01 |
CRP (mg/L) | 23.75 (43.67) | 15.39 (30.52) | 16.03 (32.64) | 18.26 (36.73) | < 0.01 | 0.02 | 0.16 |